This is the major issue for this company. The dilution coming before any money comes through the door will be off the charts.
The reality is that they simply can't make those payments.
Approx shares on issue: - 1,921,126,413
If you were to assume that all the below are exercised along with the shares issued:
81,000,000.00 + 73,000,000.00 + 50,000,000.00 + 12,500,000.00 + 150,000,000.00 + 30,000,000.00 + 150,000,000.00
Yes the money will come in for the options but its a long time post the completion payments need to be made.
They won't be paying the milestone payments in cash, they will be paying in shares.
So you need to add another $20,000,000.00 at say $0.035
Which will be another 571,428,571 shares
Cerium has a vested interest now to keep the share price low.
So existing shareholders are going to be diluted by 1,030,558,571 new shares on offer.
So basically 50%. That is absolutely staggering.
This is before they raise funds also.
$20,000,000.00 0.035 571428571.4 1 81000000 2 73000000 3 50000000 4 12500000 5 20000000 6 12500000 7 150000000 8 30000000 9 130000 10 30000000 11 Additional 1030558571 ![]()
- Forums
- ASX - By Stock
- EPM
- 10 Cent Party
10 Cent Party, page-2682
-
-
- There are more pages in this discussion • 342 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPM (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.00M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $1.641K | 205.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2438572 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 926837 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2438572 | 0.007 |
6 | 3782472 | 0.006 |
7 | 4351145 | 0.005 |
3 | 2487888 | 0.004 |
4 | 2591666 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 926837 | 1 |
0.009 | 1350000 | 2 |
0.010 | 4919967 | 7 |
0.011 | 2342422 | 2 |
0.012 | 592895 | 3 |
Last trade - 14.54pm 15/07/2024 (20 minute delay) ? |
Featured News
EPM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online